Early Stroke Treatment "EST"

Completed

Phase N/A Results

Summary of Purpose

To assess the effect of monosialoganglioside GM-1 in improving recovery in patients who have experienced an ischemic supratentorial stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 November 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Fidia S.p.A., Abano Terme, Padua, Italy

Trial Design

Randomized, double-blind, placebo-controlled trial of 792 patients at 16 centers.

Contacts

Not available